Clinical Trial: An Open-Label Safety Study of A-101 Solution

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: An Open-Label Study of the Safety of A-101 Solution 40% in Subjects With Seborrheic Keratosis on the Trunk, Extremities and Face.

Brief Summary: This is an open-label safety study. During this study, the investigator will identify 4 eligible SK Target Lesions on each subject on the trunk, extremities and face.

Detailed Summary: This is an open-label safety study. During this study, the investigator will identify 4 eligible SK Target Lesions on each subject on the trunk, extremities and face. The Target Lesions will be treated a maximum of 4 times.
Sponsor: Aclaris Therapeutics, Inc.

Current Primary Outcome: Percent of lesions clear Scale [ Time Frame: Study day 148 ]

Original Primary Outcome: Percent of lesions clear [ Time Frame: Study day 148 ]

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Aclaris Therapeutics, Inc.

Dates:
Date Received: January 26, 2016
Date Started: January 2016
Date Completion:
Last Updated: December 1, 2016
Last Verified: December 2016